Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron vs pethidine vs dexamethasone for prevention of postoperative shivering after arthroscopic knee surgery
IRCT20190325043107N79Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ondansetron, pethidine and dexamethasone in postanesthetic shivering (PAS) and postoperative nausea and vomiting (PONV) (3 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Postoperative nausea and vomiting and Postoperative shivering prevention. Started Jun 2026; status: completed.
02
Drugs
ondansetronpethidinedexamethasone
03
Conditions
postanesthetic shivering (PAS)postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20190325043107N79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N79.